CIK: 0001825034 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $106,883 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INDA | ISHARES TR | 577,144 | $24,090 | 22.5% | $41.74 | — | MSCI INDIA ETF | 46429B598 |
| — | 23ANDME HOLDING CO | 10,243,122 | $22,125 | 20.7% | $3.83 | — | CLASS A COM | 90138Q108 |
| PMVP | PMV PHARMACEUTICALS INC | 2,336,909 | $20,331 | 19.0% | $39.23 | -72.8% | COM | 69353Y103 |
| ALEC | ALECTOR INC | 980,894 | $9,054 | 8.5% | $12.43 | -29.8% | COM | 014442107 |
| — | RAPT THERAPEUTICS INC | 432,900 | $8,571 | 8.0% | $19.75 | — | COM | 75382E109 |
| FHTX | FOGHORN THERAPEUTICS INC | 1,261,261 | $8,047 | 7.5% | $19.16 | -60.6% | COM | 344174107 |
| ORIC | ORIC PHARMACEUTICALS INC | 747,550 | $4,403 | 4.1% | $28.69 | -88.2% | COM | 68622P109 |
| FFBC | FIRST FINL BANCORP OH | 173,576 | $4,206 | 3.9% | $12.77 | +69.9% | COM | 320209109 |
| — | NGM BIOPHARMACEUTICALS INC | 746,674 | $3,748 | 3.5% | $30.30 | — | COM | 62921N105 |
| TNYA | TENAYA THERAPEUTICS INC | 915,705 | $1,841 | 1.7% | $21.49 | -88.6% | COM | 87990A106 |
| — | SURROZEN INC | 802,963 | $467 | 0.4% | $7.08 | — | COM | 86889P109 |